Science & Technology
At-Home Minimally Invasive Tacrolimus Plasma Level Monitoring Device
Department of Defense — Defense Health Agency
Opportunity #: HT9425-23-C-0072
Award Ceiling
$1.3M
Award Floor
$1.3M
Close Date
Jan 28, 2026
Total Funding
$1.3M
Expected Awards
1
Posted Date
Sep 25, 2023
Cost Sharing Required
No
Grants.gov ID
sbir-HT9425-23-C-0072
Description
SBIR Phase Phase II award: "At-Home Minimally Invasive Tacrolimus Plasma Level Monitoring Device" awarded to REAL-TIME ANALYZERS INC in MIDDLETOWN, Connecticut. Funded by Department of Defense (Defense Health Agency). Award amount: $1,299,212. The SBIR/STTR programs fund innovative research and development by small businesses, with Phase I for feasibility studies and Phase II for full R&D.
Eligible Applicants
Small businesses
Apply on Grants.gov
Always verify details and apply through the official Grants.gov portal. Information here may not reflect the latest changes.
View on Grants.govDisclaimer: This information is sourced from Grants.gov and may not reflect the most current details. Always verify eligibility requirements, deadlines, and application procedures on the official program website before applying.